Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ProQR Therapeutics N.V. buy Vassago1

Start price
31.03.23 / 50%
Target price
Performance (%)
End price
This prediction ended on 02.04.23 with a price of €2.04. The prediction had a final performance of 13.41%. Vassago1 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
ProQR Therapeutics N.V. -2.360% -2.360% 5.847%
iShares Core DAX® -0.205% 2.949% 17.330%
iShares Nasdaq 100 1.613% 5.877% 37.451%
iShares Nikkei 225® -0.740% -1.256% 11.847%
iShares S&P 500 0.267% 3.240% 29.308%

According to Vassago1 what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?

Could be very worthwhile Investment >20% year

Comments by Vassago1 for this prediction

In the thread ProQR Therapeutics N.V. diskutieren

Buy ProQR Therapeutics N.V.

In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) 13.41%
Target price
Ends at 31.03.24

Buy beendet